| ABTS | 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) |
| BMI | Body mass index |
| BP | Blood pressure |
| CRP | C-reactive protein |
| CVD | Cardiovascular disease |
| FRAP | Ferric reducing antioxidant power |
| DBP | Diastolic blood pressure |
| DRI | Dietary reference intake |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl |
| FMD | Flow-mediated dilation |
| GAE | gallic acid equivalent |
| GIP | Gastric inhibitory polypeptide |
| GLP-1 | Glucagon-like peptide-1 |
| HbA1c | Glycated hemoglobin |
| HDL | High-density lipoprotein |
| HOMA-IR | Homeostatic model assessment for insulin resistance |
| LDL | Low-density lipoprotein |
| MetS | Metabolic syndrome |
| MUFA | Monounsaturated fatty acid |
| NF-κB | Nuclear factor kappa B |
| ORAC | Oxygen radical absorbance capacity |
| oxLDL | oxidised-LDL |
| PUFA | Polyunsaturated fatty acids |
| RCT | Randomized controlled trials |
| RDA | Recommended dietary allowance |
| ROS | Reactive oxygen species |
| SBP | Systolic blood pressure |
| SFA | Saturated fatty acids |
| sVCAM-1 | Soluble vascular cell adhesion molecule-1 |
| T2DM | Type 2 diabetes mellitus |
| TC | Total cholesterol |
| TE | Trolox equivalent |
| TEAC | Trolox equivalent antioxidant capacity |
| TG | Tryglycerides |
| TNFα | Tumour necrosis factor-alpha |
| TPP | Total polar phenolics |